Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstracts at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

by NASDAQ Market News April 28, 2021

NASDAQ Market News
Click here to email author

Stanley R. Frankel, MD, FACP joins Cytovia Therapeutics as Chief Medical Officer

Interim Analysis from the Ongoing Open-Label Phase III Extension Study Shows Sustained Benefits of PXT3003 for Patients with Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)

Ads